Showing results (1751-1760 of 2,091) with videos related to

Sort By:
Pageof 210
Environmental Science & Technology|April 29, 2004
Multimedia fate model for hexachlorocyclohexane in Tianjin, ChinaHongying Cao, Shu Tao, Fuliu Xu, et al.
American Journal of Cancer Research|May 11, 2023
ZY-444 inhibits the growth and metastasis of prostate cancer by targeting TNFAIP3 through TNF signaling pathwayMeng-Ting Han, Hua Pei, Qi-Qi Sun, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 25, 2017
Dilation Time in Endoscopic Papillary Balloon Dilation for Common Bile Duct StonesYong-Hua Shen, Liu-Qing Yang, Yu-Ling Yao, et al.
Malaria Journal|July 11, 2014
Genetic diversity and population structure of Plasmodium vivax in Central ChinaYaobao Liu, Sarah Auburn, Jun Cao, et al.
Journal of Chromatography. A|January 17, 2018
Miniaturized solid-phase extraction of macrolide antibiotics in honey and bovine milk using mesoporous MCM-41 silica as sorbentLi-Jing Du, Ling Yi, Li-Hong Ye, et al.
Food Chemistry|May 13, 2018
Crown ether microfunctionalized carbon nanotubes for dispersive micro-solid-phase extraction of sudan dyes and their metabolitesLi-Jing Du, Yu-Han Hu, Qiu-Yan Wang, et al.
Investigational New Drugs|February 10, 2020
Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trialJun Cao, Quchang Ouyang, Shusen Wang, et al.
Ecotoxicology and Environmental Safety|February 15, 2021
A green rust-coated expanded perlite particle electrode-based adsorption coupling with the three-dimensional electrokinetics that enhances hexavalent chromium removalTao Huang, Dongping Song, Xiangping Chen, et al.
American Journal of Cancer Research|July 16, 2015
Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancersQiang Zhao, Jun Cao, Yi-Chen Wu, et al.
Breast Cancer Research and Treatment|June 12, 2020
Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemiaJinfeng Zhang, Mingxi Lin, Yizi Jin, et al.
Pageof 210